These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16871689)

  • 1. Clopidogrel for the prevention of atherothrombotic events.
    Almanaseer Y; Desai DM
    N Engl J Med; 2006 Jul; 355(4):420; author reply 420-1. PubMed ID: 16871689
    [No Abstract]   [Full Text] [Related]  

  • 2. Clopidogrel for the prevention of atherothrombotic events.
    Rozenman Y
    N Engl J Med; 2006 Jul; 355(4):419; author reply 420-1. PubMed ID: 16871688
    [No Abstract]   [Full Text] [Related]  

  • 3. Clopidogrel for the prevention of atherothrombotic events.
    Kongsaengdao S; Arayawichanont A
    N Engl J Med; 2006 Jul; 355(4):419-20; author reply 420-1. PubMed ID: 16874903
    [No Abstract]   [Full Text] [Related]  

  • 4. Clopidogrel for the prevention of atherothrombotic events.
    Kamalesh M
    N Engl J Med; 2006 Jul; 355(4):420; author reply 420-1. PubMed ID: 16874904
    [No Abstract]   [Full Text] [Related]  

  • 5. Economic evaluation of clopidogrel plus aspirin for secondary prevention of cardiovascular events in Canada for patients with established cardiovascular disease: Results from the CHARISMA trial.
    Chen J; Shi C; Mahoney EM; Dunn ES; Rinfret S; Caro JJ; O'Brien J; El-Hadi W; Bhatt DL; Topol EJ; Cohen DJ
    Can J Cardiol; 2011; 27(2):222-31. PubMed ID: 21459271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin or clopidogrel for secondary prevention of cardiovascular events: is there a winner?
    Gaspoz JM; de Moerloose P
    Am J Med; 2004 Jun; 116(12):850-2. PubMed ID: 15178502
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost-effectiveness of clopidogrel plus aspirin versus aspirin alone.
    Eriksson P
    Ann Intern Med; 2005 Sep; 143(6):464; author reply 464-5. PubMed ID: 16172447
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost-effectiveness of clopidogrel plus aspirin versus aspirin alone.
    Rothberg M
    Ann Intern Med; 2005 Sep; 143(6):464; author reply 464-5. PubMed ID: 16172448
    [No Abstract]   [Full Text] [Related]  

  • 9. Benefit of aspirin not surpassed by combining clopidogrel with aspirin in dual anti-platelet prevention of atherothrombotic events in high-risk patients : drug trends in cardiology.
    Cardiovasc J S Afr; 2006; 17(2):96, 98; discussion 98. PubMed ID: 16733607
    [No Abstract]   [Full Text] [Related]  

  • 10. Clopidogrel and [symbol: see text] ticlopidine--improvements on aspirin?
    Drug Ther Bull; 1999 Aug; 37(8):59-61. PubMed ID: 10696686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The "clopidogrel resistance" trap.
    Serebruany VL
    Am J Cardiol; 2007 Sep; 100(6):1044-6. PubMed ID: 17826395
    [No Abstract]   [Full Text] [Related]  

  • 12. Clopidogrel versus aspirin and esomeprazole to prevent recurrent bleeding.
    Wolk MJ; Jacobs AK
    N Engl J Med; 2005 Apr; 352(16):1716-8; author reply 1716-8. PubMed ID: 15843675
    [No Abstract]   [Full Text] [Related]  

  • 13. Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.
    Bhatt DL; Topol EJ;
    Am Heart J; 2004 Aug; 148(2):263-8. PubMed ID: 15308995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin, ticlopidine and clopidogrel in and out of the catheterization laboratory.
    Berger PB
    J Invasive Cardiol; 1999 Jun; 11 Suppl A():20A-29A. PubMed ID: 10745607
    [No Abstract]   [Full Text] [Related]  

  • 15. Clopidogrel for the prevention of atherothrombotic events.
    Rabinstein AA
    N Engl J Med; 2006 Jul; 355(4):418-9; author reply 420-1. PubMed ID: 16870924
    [No Abstract]   [Full Text] [Related]  

  • 16. [Combination of clopidogrel and aspirin was no better than aspirin alone for prevention of atherothrombotic events in stable patients. Results of CHARISMA].
    Granitskiĭ NA
    Kardiologiia; 2006; 46(5):73-5. PubMed ID: 16858363
    [No Abstract]   [Full Text] [Related]  

  • 17. Aspirin and clopidogrel resistance.
    Fosburgh D
    Mayo Clin Proc; 2006 Jul; 81(7):989; author reply 990. PubMed ID: 16835978
    [No Abstract]   [Full Text] [Related]  

  • 18. Aspirin and clopidogrel resistance: an emerging clinical entity.
    Johns A; Fisher M; Knappertz V
    Eur Heart J; 2006 Jul; 27(14):1754; author reply 1754-5. PubMed ID: 16751205
    [No Abstract]   [Full Text] [Related]  

  • 19. High-sensitivity C-reactive protein and clopidogrel treatment in patients at high risk of cardiovascular events: a substudy from the CHARISMA trial.
    Weber M; Bhatt DL; Brennan DM; Hankey GJ; Steinhubl SR; Johnston SC; Montalescot G; Mak KH; Fox KA; Easton DJ; Topol EJ; Hamm CW;
    Heart; 2011 Apr; 97(8):626-31. PubMed ID: 21393433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.
    Bhatt DL; Fox KA; Hacke W; Berger PB; Black HR; Boden WE; Cacoub P; Cohen EA; Creager MA; Easton JD; Flather MD; Haffner SM; Hamm CW; Hankey GJ; Johnston SC; Mak KH; Mas JL; Montalescot G; Pearson TA; Steg PG; Steinhubl SR; Weber MA; Brennan DM; Fabry-Ribaudo L; Booth J; Topol EJ;
    N Engl J Med; 2006 Apr; 354(16):1706-17. PubMed ID: 16531616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.